Market Place
Sourcing Support
Arrowhead Pharma’s Redemplo Receives Approval in US
18 Nov 2025 //
FDA
Mylan’s Generics Aprepitant Receives Tentative Approval in US
17 Nov 2025 //
FDA
Biocon’s Generics Tofacitinib Receives Tentative Approval in US
17 Nov 2025 //
FDA
Marksans Pharma’s Generics Loperamide HCl Receives Approval in US
17 Nov 2025 //
FDA
Avet Lifes’ Generics Diphenhydramine HCl Receives Approval in US
14 Nov 2025 //
FDA
Apotex’s Generics Rivaroxaban Receives Approval in US
14 Nov 2025 //
FDA
Navinta’s Generics Diazepam Receives Approval in US
14 Nov 2025 //
FDA
Aurobindo Pharma’s Generics Fosfomycin Receives Approval in US
14 Nov 2025 //
FDA
Alembic’s Generics Diltiazem HCl Receives Approval in US
14 Nov 2025 //
FDA
Accord’s Generics Lenalidomide Receives Approval in US
14 Nov 2025 //
FDA
Hainan Poly Pharm’s Generics Voriconazole Receives Approval in US
14 Nov 2025 //
FDA
MSN’s Generics Brivaracetam Receives Approval in US
13 Nov 2025 //
FDA
Zyd Pharms’ Generics Leuprolide Acetate Receives Approval in US
13 Nov 2025 //
FDA
Kura Oncology’s Komzifti Receives Approval In US
13 Nov 2025 //
FDA
Chia Tai’s Generics Palbociclib Receives Tentative Approval in US
13 Nov 2025 //
FDA
Shanghai Henlius’s Biologics Poherdy Receives Approval In US
13 Nov 2025 //
FDA
Amneal’s Generics Iohexol Receives Approval in US
13 Nov 2025 //
FDA
Aspiro’s Generics Verapamil HCl Receives Approval in US
13 Nov 2025 //
FDA
Teva’ Generics Atorvastatin Calcium Receives Approval in US
13 Nov 2025 //
FDA
Laurus’s Generics Sitagliptin Receives Tentative Approval In US
12 Nov 2025 //
FDA
Gland’s Generics Leucovorin Calcium Receives Approval In US
12 Nov 2025 //
FDA
Zydus’s Generics Diroximel Fumarate Receives Approval In US
12 Nov 2025 //
FDA
Alembic’s Generics Dexlansoprazole Receives Approval In US
12 Nov 2025 //
FDA
Padagis’s Generics Diazepam Receives Tentative Approval In US
12 Nov 2025 //
FDA
Sandoz’s Generics Carbidopa Receives Tentative Approval In US
12 Nov 2025 //
FDA
Macleods’s Generics Vortioxetine HBr Recieves Approval In US
10 Nov 2025 //
FDA
Freseni Kabi’s Generics Dalbavancin HCl Receives Approval in US
10 Nov 2025 //
FDA
Cosette’s Generics Ciprofloxacin HCl Receives Approval in US
10 Nov 2025 //
FDA
Hainan`s Generics Carfilzomib Receives Tentative Approval In US
07 Nov 2025 //
FDA
Alembic’s Generics Sumatriptan Succinate Receives Approval in US
06 Nov 2025 //
FDA
Steriscience’s Generics Doxycycline Receives Approval in US
06 Nov 2025 //
FDA
Fresenius’s Generics Sugammadex Receives Tentative Approval In US
06 Nov 2025 //
FDA
Zydus’s Generics Olaparib Receives Tentative Approval In US
06 Nov 2025 //
FDA
Qilu’s Generics Abemaciclib Receives Tentative Approval In US
06 Nov 2025 //
FDA
Alembic’s Generics Dasatinib Receives Approval In US
06 Nov 2025 //
FDA
Ascent’s Generics Sodium Oxybate Receives Approval in US
05 Nov 2025 //
FDA
Laurus’s Generics Macitentan Receives Approval in US
05 Nov 2025 //
FDA
Umedica’s Generics Diclofenac Sodium Receives Approval in US
05 Nov 2025 //
FDA
Rhodes’s Generics Maraviroc Receives Approval in US
04 Nov 2025 //
FDA
Shandong’s Generics Isoflurane Receives Approval in US
04 Nov 2025 //
FDA
Amneal’s Generics Phytonadione Receives Approval in US
04 Nov 2025 //
FDA
MSN’s Generics Mirabegron Receives Approval in US
04 Nov 2025 //
FDA
Rising’s Generics Sulfasalazine Receives Approval in US
04 Nov 2025 //
FDA
MSN’s Generics Irbesartan Receives Approval in US
04 Nov 2025 //
FDA
Unichem’s Generics Apixaban Receives Tentative Approval In US
04 Nov 2025 //
FDA
Alkem’s Generics Bempedoic Acid Receives Tentative Approval In US
04 Nov 2025 //
FDA
MSN Lab’s Generics Vibegron Receives Tentative Approval In US
04 Nov 2025 //
FDA
Aurobindo Pharma’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Dr Reddys’s Generics Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
Mylan’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin, Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Vortioxetine HBr Receives Tentative Approval in US
03 Nov 2025 //
FDA
SPH Zhongxi’s Generics Eslicarbazepine Receives Approval in US
03 Nov 2025 //
FDA
UCB’s Kygevvi Receives Approval in US
03 Nov 2025 //
FDA
Cipla’s Generics Enzalutamide Receives Tentative Approval In US
03 Nov 2025 //
FDA
Zydus’s Generics Budesonide Receives Tentative Approval In US
03 Nov 2025 //
FDA
Dr Reddy’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Apotex’s Generics Axitinib Receives Approval in US
30 Oct 2025 //
FDA
Novugen’s Generics Everolimus Receives Approval in US
30 Oct 2025 //
FDA
